Dr Reddy's kicks off derma, neurology NDA filings
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has announced its first bucket of New Drug Application (NDA) filings with the US FDA for its proprietary products business targeting the dermatology and neurology segments.